{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T07:46:27Z","timestamp":1782719187392,"version":"3.54.5"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lasers Med Sci"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    To evaluate the effectiveness and safety of subthreshold micropulse laser (MPL) in patients with residual subretinal fluid (SRF) after vitrectomy for myopic traction maculopathy (MTM).\u00a0This was a prospective, pilot randomized controlled trial. We recruited eyes with residual SRF\u2265200\u00a0\u03bcm on OCT at 1-month follow-up after vitrectomy for macular hole retinal detachment (MHRD) and macular schisis with foveal detachment (MSRD). Forty eligible patients were randomized to control and MPL group in a 1:1 allocation ratio. Patients in the MPL group received MPL treatment 1-month after surgery by a same doctor and the procedure was repeated at 1-month intervals when necessary. Follow-up endpoint was defined as either complete absorption of subretinal fluid (SRF) or a minimum postoperative observation period of 6 months.\u00a0The median follow-up time was 6 months (range: 3\u201328 months). Postoperatively, BCVA was significantly improved, and macular thickness was significantly reduced (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.001) compared with preoperative baseline. The patients in the MPL group received 2.05\u2009\u00b1\u20090.89 (range 1\u20133) times of MPL. The Kaplan Meier curve showed a trend that the MPL group had better SRF absorption, but the difference is not significant between the two groups (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.33). No severe complications in both groups during the follow-up.\u00a0MPL is a safe non-invasive procedure in pathologic myopia patients. The limited therapeutic effect of MPL on SRF absorption may reflect the compromised RPE function resulting from progressive thinning and atrophy in highly myopic eyes.\n                  <\/jats:p>","DOI":"10.1007\/s10103-026-04929-x","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T07:11:21Z","timestamp":1782717081000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Subthreshold micropulse laser for subretinal fluid after vitrectomy in myopic traction maculopathy: a pilot randomized controlled trial"],"prefix":"10.1007","volume":"41","author":[{"given":"Xifang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixia","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Bing","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"4929_CR1","doi-asserted-by":"crossref","unstructured":"Li J, Liu B, Li Y, Zhao X, Chen S, Huang X, Lian P, Li T, Jin C, Liang X, Lu L\u00a0(2021) CLINICAL CHARACTERISTICS OF EYES WITH DIFFERENT GRADES OF MYOPIC TRACTION MACULOPATHY: Based on the New Classification System. Retina 41(7):1496\u20131501","DOI":"10.1097\/IAE.0000000000003043"},{"issue":"18","key":"4929_CR2","doi-asserted-by":"publisher","first-page":"3218","DOI":"10.1038\/s41433-025-04072-x","volume":"39","author":"K Ohno-Matsui","year":"2025","unstructured":"Ohno-Matsui K (2025) Pathologic myopia. Eye (Lond) 39(18):3218\u20133228. https:\/\/doi.org\/10.1038\/s41433-025-04072-x","journal-title":"Eye (Lond)"},{"key":"4929_CR3","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.preteyeres.2018.10.005","volume":"69","author":"J Ruiz-Medrano","year":"2019","unstructured":"Ruiz-Medrano J, Montero JA, Flores-Moreno I, Arias L, Garcia-Layana A, Ruiz-Moreno JM (2019) Myopic maculopathy: current status and proposal for a new classification and grading system (ATN). Prog Retin Eye Res 69:80\u2013115. https:\/\/doi.org\/10.1016\/j.preteyeres.2018.10.005","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"4929_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-021-02087-y","volume":"21","author":"S Li","year":"2021","unstructured":"Li S, Li T, Wang X et al (2021) Natural course of myopic traction maculopathy and factors influencing progression and visual acuity. BMC Ophthalmol 21(1):347. https:\/\/doi.org\/10.1186\/s12886-021-02087-y","journal-title":"BMC Ophthalmol"},{"issue":"4","key":"4929_CR5","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1177\/11206721231210693","volume":"34","author":"AM Mansour","year":"2024","unstructured":"Mansour AM, Lopez-Guajardo L, Belotto S et al (2024) Recovery course of persistent posterior subretinal fluid after successful repair of rhegmatogenous retinal detachment. Eur J Ophthalmol 34(4):1217\u20131227. https:\/\/doi.org\/10.1177\/11206721231210693","journal-title":"Eur J Ophthalmol"},{"issue":"8","key":"4929_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59081388","volume":"59","author":"F Bodea","year":"2023","unstructured":"Bodea F, Bungau SG, Bogdan MA et al (2023) Micropulse laser therapy as an integral part of eye disease management. Medicina 59(8):1388. https:\/\/doi.org\/10.3390\/medicina59081388","journal-title":"Medicina"},{"key":"4929_CR7","doi-asserted-by":"publisher","DOI":"10.1177\/03000605231194462","author":"X Feng","year":"2023","unstructured":"Feng X, Li Y, Wu M et al (2023) Efficacy of subthreshold micropulse laser photocoagulation therapy versus anti-vascular endothelial growth factor therapy for refractory macular edema secondary to non-ischemic branch retinal vein occlusion. J Int Med Res. https:\/\/doi.org\/10.1177\/03000605231194462","journal-title":"J Int Med Res"},{"issue":"6","key":"4929_CR8","doi-asserted-by":"publisher","first-page":"921","DOI":"10.18240\/ijo.2023.06.14","volume":"16","author":"J-J Guo","year":"2023","unstructured":"Guo J-J, Wan J-J (2023) Efficacy and safety of subthreshold micropulse laser in the treatment of acute central serous chorioretinopathy. Int J Ophthalmol 16(6):921\u2013927. https:\/\/doi.org\/10.18240\/ijo.2023.06.14","journal-title":"Int J Ophthalmol"},{"issue":"2","key":"4929_CR9","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3390\/jcm8020242","volume":"8","author":"M Gaw\u02dbecki","year":"2019","unstructured":"Gaw\u02dbecki M (2019) Micropulse Laser Treatment of Retinal Diseases. J Clin Med 8(2):242. https:\/\/doi.org\/10.3390\/jcm8020242","journal-title":"J Clin Med"},{"key":"4929_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11133906","author":"Y Meng","year":"2022","unstructured":"Meng Y, Long K, Chen J, Luo J (2022) Effect of high myopia on delayed absorption of subretinal fluid after scleral buckling surgery. J Clin Med. https:\/\/doi.org\/10.3390\/jcm11133906","journal-title":"J Clin Med"},{"issue":"3","key":"4929_CR11","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1007\/s40123-023-00698-w","volume":"12","author":"C Iovino","year":"2023","unstructured":"Iovino C, Iodice CM, Pisani D et al (2023) Yellow Subthreshold Micropulse Laser in Retinal Diseases: An In-Depth Analysis and Review of the Literature. Ophthalmol Ther 12(3):1479\u20131500. https:\/\/doi.org\/10.1007\/s40123-023-00698-w","journal-title":"Ophthalmol Ther"},{"issue":"3","key":"4929_CR12","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1159\/000481703","volume":"8","author":"G Soudier","year":"2017","unstructured":"Soudier G, Gaudric A, Gualino V, Nardin M, Speeg-Schatz C, Gaucher D (2017) Epiretinal Membrane in Dome-Shaped Macula Complicated with Serous Retinal Detachment: Transient Efficacy of Surgery. Case Rep Ophthalmol 8(3):515\u2013520. https:\/\/doi.org\/10.1159\/000481703","journal-title":"Case Rep Ophthalmol"},{"key":"4929_CR13","doi-asserted-by":"publisher","first-page":"100821","DOI":"10.1016\/j.ajoc.2020.100821","volume":"19","author":"MP Martin-Gutierrez","year":"2020","unstructured":"Martin-Gutierrez MP, Georgiou M, Michaelides M (2020) Subfoveal retinal detachment associated with dome-shaped macula in a 6 year-old child: Comparison with other case reports and systematic review of the literature regarding dome-shaped macula in children. Am J Ophthalmol Case Rep 19:100821. https:\/\/doi.org\/10.1016\/j.ajoc.2020.100821","journal-title":"Am J Ophthalmol Case Rep"},{"issue":"1","key":"4929_CR14","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ajo.2014.09.026","volume":"159","author":"F Viola","year":"2015","unstructured":"Viola F, Dell\u2019Arti L, Benatti E et al (2015) Choroidal findings in dome-shaped macula in highly myopic eyes: a longitudinal study. Am J Ophthalmol 159(1):44\u201352. https:\/\/doi.org\/10.1016\/j.ajo.2014.09.026","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"4929_CR15","doi-asserted-by":"publisher","first-page":"975","DOI":"10.18240\/ijo.2022.06.16","volume":"15","author":"Y Huang","year":"2022","unstructured":"Huang Y, Qi Y, Wei WB, Duan AL (2022) Long-term outcome of pathologic myopic foveoschisis treated with posterior scleral reinforcement followed by vitrectomy. Int J Ophthalmol 15(6):975\u2013982. https:\/\/doi.org\/10.18240\/ijo.2022.06.16","journal-title":"Int J Ophthalmol"},{"issue":"1","key":"4929_CR16","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1186\/s12886-022-02497-6","volume":"22","author":"Q He","year":"2022","unstructured":"He Q, Wang X, Shi Q, Xie C, Xue A, Wei R (2022) Posterior scleral reinforcement for the treatment of myopic traction maculopathy. BMC Ophthalmol 22(1):273. https:\/\/doi.org\/10.1186\/s12886-022-02497-6","journal-title":"BMC Ophthalmol"},{"issue":"2","key":"4929_CR17","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s00417-019-04550-5","volume":"258","author":"K Cao","year":"2020","unstructured":"Cao K, Wang J, Zhang J et al (2020) The effectiveness and safety of posterior scleral reinforcement with vitrectomy for myopic foveoschisis treatment: a systematic review and meta-analysis. Graefes Arch Clin Exp Ophthalmol 258(2):257\u2013271. https:\/\/doi.org\/10.1007\/s00417-019-04550-5","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"4929_CR18","first-page":"389","volume":"14","author":"S Zhu","year":"2022","unstructured":"Zhu S, Xue A, Li H et al (2022) Posterior scleral contraction to treat myopic traction maculopathy at different stages. Am J Transl Res 14(1):389\u2013395. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/35173857","journal-title":"Am J Transl Res"},{"issue":"1","key":"4929_CR19","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s40662-025-00446-0","volume":"12","author":"NV Radke","year":"2025","unstructured":"Radke NV, Ruamviboonsuk P, Steel DH et al (2025) Controversies, consensuses, and guidelines on macular hole surgery by the Asia-Pacific Vitreo-retina Society (APVRS) and the Asia-Pacific Academy of Professors in Ophthalmology (AAPPO). Eye Vis (Lond) 12(1):30. https:\/\/doi.org\/10.1186\/s40662-025-00446-0","journal-title":"Eye Vis (Lond)"},{"issue":"6","key":"4929_CR20","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.18240\/ijo.2024.06.13","volume":"17","author":"J Deng","year":"2024","unstructured":"Deng J, Sun WT, Gong K, Wang LP, Li FZ (2024) Internal limiting membrane peeling combined with silicone oil or air tamponade for highly myopic foveoschisis. Int J Ophthalmol 17(6):1079\u20131085. https:\/\/doi.org\/10.18240\/ijo.2024.06.13","journal-title":"Int J Ophthalmol"},{"issue":"3","key":"4929_CR21","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1097\/IAE.0b013e3182670fd7","volume":"33","author":"R Mancino","year":"2013","unstructured":"Mancino R, Ciuffoletti E, Martucci A et al (2013) Anatomical and functional results of macular hole retinal detachment surgery in patients with high myopia and posterior staphyloma treated with perfluoropropane gas or silicone oil. Retina 33(3):586\u201392. https:\/\/doi.org\/10.1097\/IAE.0b013e3182670fd7","journal-title":"Retina"},{"issue":"2","key":"4929_CR22","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1097\/IAE.0000000000000313","volume":"35","author":"Y Qi","year":"2015","unstructured":"Qi Y, Duan AL, You QS, Jonas JB, Wang N (2015) Posterior scleral reinforcement and vitrectomy for myopic foveoschisis in extreme myopia. Retina 35(2):351\u20137. https:\/\/doi.org\/10.1097\/IAE.0000000000000313","journal-title":"Retina"},{"key":"4929_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics15131688","author":"AE Ranetti","year":"2025","unstructured":"Ranetti AE, Stanca HT, Munteanu M, Bievel Radulescu R, Stanca S (2025) Blue light and green light fundus autofluorescence, complementary to optical coherence tomography, in age-related macular degeneration evaluation. Diagnostics (Basel). https:\/\/doi.org\/10.3390\/diagnostics15131688","journal-title":"Diagnostics (Basel)"},{"issue":"5","key":"4929_CR24","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1111\/ceo.14090","volume":"50","author":"S Parrulli","year":"2022","unstructured":"Parrulli S, Cozzi M, Airaldi M et al (2022) Quantitative autofluorescence findings in patients undergoing hydroxychloroquine treatment. Clin Exp Ophthalmol 50(5):500\u2013509. https:\/\/doi.org\/10.1111\/ceo.14090","journal-title":"Clin Exp Ophthalmol"}],"container-title":["Lasers in Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-026-04929-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10103-026-04929-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-026-04929-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T07:11:30Z","timestamp":1782717090000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10103-026-04929-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4929"],"URL":"https:\/\/doi.org\/10.1007\/s10103-026-04929-x","relation":{},"ISSN":["1435-604X"],"issn-type":[{"value":"1435-604X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"assertion":[{"value":"6 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"136"}}